Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial

Abstract Background Early glucose lowering intervention in subjects with type 2 diabetes mellitus was demonstrated to be beneficial in terms of micro- and macrovascular risk reduction. However, most of currently ongoing cardiovascular outcome trials are performed in subjects with manifest atheroscle...

Full description

Bibliographic Details
Main Authors: Norbert J. Tripolt, Felix Aberer, Regina Riedl, Jasmin Url, Gudrun Dimsity, Andreas Meinitzer, Tatjana Stojakovic, Faisal Aziz, Ronald Hödl, Gabriele Brachtl, Dirk Strunk, Marianne Brodmann, Franz Hafner, Harald Sourij
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Cardiovascular Diabetology
Subjects:
Linagliptin
Flow mediated dilatation
RCT
DPP-4 inhibitor
Type 2 diabetes
Coronary artery disease
Online Access:http://link.springer.com/article/10.1186/s12933-018-0716-x

Internet

http://link.springer.com/article/10.1186/s12933-018-0716-x

Similar Items